GITNUXREPORT 2026

Surgery Statistics

Cardiac surgeries are declining as safer, minimally invasive procedures rapidly gain popularity.

Alexander Schmidt

Research Analyst specializing in technology and digital transformation trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

Appendectomies in the US numbered 340,000 in 2021, with laparoscopic approach in 85% reducing stays to 1 day.

Statistic 2

Cholecystectomies reached 1.2 million globally in 2022, bile duct injuries at 0.5% in lap vs. 0.2% open.

Statistic 3

Hernia repairs total 800,000 US annually, mesh usage in 95% with recurrence <2% at 5 years.

Statistic 4

Colorectal resections for cancer hit 150,000 US in 2023, laparoscopic in 60% with 80% 5-year survival.

Statistic 5

Bariatric surgeries grew to 260,000 US in 2022, sleeve gastrectomy 60% with 50-70% excess weight loss.

Statistic 6

Colectomy volumes declined 10% post-COVID due to screening pauses, per 2023 NIS data.

Statistic 7

Pancreatoduodenectomies (Whipple) mortality fell to 2-5% in high-volume centers (>20/year).

Statistic 8

Inguinal hernia recurrence post-laparoscopic TEP is 3.6% vs. 1.7% open Lichtenstein at 5 years.

Statistic 9

Esophagectomies number 8,000 US yearly, minimally invasive reducing pulmonary complications by 40%.

Statistic 10

Ventral hernia repairs with biologic mesh show 15% recurrence vs. 25% synthetic in contaminated fields.

Statistic 11

Adrenalectomies for pheochromocytoma total 2,000 US, laparoscopic in 90% with <1% mortality.

Statistic 12

Splenectomies declined 60% since 2000 due to angioembolization, now 40,000 US yearly.

Statistic 13

Gastrectomies for gastric cancer: 5-year survival post-R0 resection 70% in early stages.

Statistic 14

Liver resections for HCC reached 50,000 globally, robotic approach halving blood loss.

Statistic 15

Small bowel obstructions require surgery in 20%, adhesiolysis with 10% recurrence risk.

Statistic 16

Thyroidectomies total 70,000 US for cancer, hypocalcemia in 30% transient post-op.

Statistic 17

Parathyroidectomies cure hyperparathyroidism in 95%, minimally invasive in 80%.

Statistic 18

Perforated ulcer surgeries: 90% survival with early lap repair, sepsis mortality 20%.

Statistic 19

In 2022, approximately 240,000 coronary artery bypass graft (CABG) surgeries were performed in the United States, marking a 5% decline from 2019 due to minimally invasive alternatives.

Statistic 20

The global market for cardiac surgery devices reached $12.5 billion in 2023, driven by an 8% annual growth in valve replacement procedures.

Statistic 21

Success rate of minimally invasive mitral valve repair surgery exceeds 95% in high-volume centers, with operative mortality under 1% as per 2021 data.

Statistic 22

In Europe, transcatheter aortic valve replacement (TAVR) procedures increased by 25% from 2020 to 2023, totaling over 100,000 annually.

Statistic 23

Postoperative atrial fibrillation occurs in 30-40% of CABG patients, contributing to 20% longer hospital stays according to a 2022 meta-analysis.

Statistic 24

Robotic-assisted cardiac surgery adoption rose to 15% of all heart valve procedures in the US by 2023, reducing blood transfusion needs by 25%.

Statistic 25

Lifetime risk of requiring heart valve surgery is 1 in 75 for men and 1 in 100 for women over age 50, per UK Biobank study.

Statistic 26

In 2021, India performed over 50,000 open-heart surgeries, with a 98% survival rate in pediatric cases at top centers.

Statistic 27

Hybrid coronary revascularization procedures grew 12% yearly, combining PCI and CABG, with 90% patency rates at 5 years.

Statistic 28

Sternal wound infections complicate 1-5% of median sternotomy cardiac surgeries, linked to 20% increased mortality.

Statistic 29

In 2023, China reported 300,000 cardiac surgeries, with off-pump CABG comprising 60% to minimize complications.

Statistic 30

5-year survival post-CABG for left main disease is 85-90%, superior to medical therapy alone per 2022 trials.

Statistic 31

Pediatric congenital heart surgery volumes in the US hit 12,000 annually, with 97% survival for simple repairs.

Statistic 32

Intra-aortic balloon pump usage in high-risk cardiac surgery dropped to 10% due to Impella devices, improving hemodynamics.

Statistic 33

Women undergoing cardiac surgery have 1.5 times higher mortality risk than men, adjusted for comorbidities per 2023 registry.

Statistic 34

Global cardiac surgery wait times average 3-6 months in public systems, leading to 10% preventable deaths.

Statistic 35

3D printing for patient-specific cardiac models reduced operative time by 22% in complex valve surgeries.

Statistic 36

In 2022, Australia performed 25,000 cardiac procedures, with Indigenous patients showing 2x complication rates.

Statistic 37

Endocarditis-related valve surgeries increased 15% post-COVID, with 40% involving multidrug-resistant organisms.

Statistic 38

AI predictive models for cardiac surgery risk achieve 92% accuracy in mortality prediction over traditional scores.

Statistic 39

Craniotomies for tumor resection in the US total 50,000 annually, with 90% gross total resection in gliomas.

Statistic 40

Anterior cervical discectomy and fusion (ACDF) procedures reached 200,000 US in 2022, 95% success for radiculopathy.

Statistic 41

Deep brain stimulation (DBS) for Parkinson's implanted in 15,000 patients yearly worldwide, improving motor scores by 50%.

Statistic 42

Aneurysm clipping vs. coiling: surgical clipping used in 30% complex cases with 92% occlusion rates.

Statistic 43

Spinal cord tumor resections: intramedullary gross total removal in 70%, neurologic preservation 85%.

Statistic 44

Endoscopic third ventriculostomy success for hydrocephalus is 70% in adults, avoiding shunt dependency.

Statistic 45

Awake craniotomy for eloquent gliomas allows 80% resection increase, preserving language function in 95%.

Statistic 46

Chiari malformation decompression surgeries total 5,000 US yearly, symptom relief in 80-90%.

Statistic 47

Pituitary adenoma transsphenoidal resections: 85% biochemical remission for acromegaly.

Statistic 48

Trigeminal neuralgia microvascular decompression yields 80% pain-free at 10 years.

Statistic 49

Stereotactic radiosurgery (SRS) for brain mets: local control 85% at 1 year, used in 50,000 cases globally.

Statistic 50

Lumbar microdiscectomies number 500,000 worldwide annually, 90% leg pain relief.

Statistic 51

Carotid endarterectomy reduces stroke risk by 65% in symptomatic stenosis >70%.

Statistic 52

Pediatric neurosurgery for spina bifida closure: 90% survival, hydrocephalus shunt in 80%.

Statistic 53

Laser interstitial thermal therapy (LITT) for epilepsy: seizure freedom in 60% focal cases.

Statistic 54

Moyamoya revascularization: stroke reduction 80% post-direct bypass in adults.

Statistic 55

Intracranial pressure monitoring in TBI: used in 20% severe cases, mortality drop 15%.

Statistic 56

Radiosurgery for trigeminal schwannoma: 95% tumor control, facial preservation 98%.

Statistic 57

Minimally invasive spine surgery (MISS) adoption 40%, blood loss 50% less than open.

Statistic 58

Arteriovenous malformation (AVM) microsurgery obliteration 95% Spetzler-Martin grade I/II.

Statistic 59

Ventriculoperitoneal shunt infections occur in 5-10%, revisions in 40% first year.

Statistic 60

Cataract surgeries worldwide exceeded 28 million in 2022, with intraocular lens implants restoring 20/40 vision in 95%.

Statistic 61

LASIK procedures in the US totaled 800,000 in 2023, 96% achieving 20/20 uncorrected vision.

Statistic 62

Retinal detachment repairs number 50,000 US annually, anatomical success 90% with vitrectomy.

Statistic 63

Glaucoma trabeculectomy surgeries: 70-80% intraocular pressure control at 5 years.

Statistic 64

Corneal transplants (PK) global volume 200,000 yearly, graft survival 90% at 1 year.

Statistic 65

Strabismus surgeries in children: 120,000 US, alignment success 75% single procedure.

Statistic 66

Diabetic vitrectomy for vitreous hemorrhage: visual acuity improvement in 80%.

Statistic 67

Pterygium excisions with conjunctival autograft: recurrence <5% vs. 30% bare sclera.

Statistic 68

Dacryocystorhinostomy (DCR) success 95% for nasolacrimal duct obstruction.

Statistic 69

Macular hole repairs with ILM peeling: anatomical closure 95%, vision gain 70%.

Statistic 70

Phacoemulsification cataract complications: posterior capsule rupture 1-2%.

Statistic 71

Refractive lens exchange for presbyopia: 90% spectacle independence post-multifocal IOL.

Statistic 72

Endothelial keratoplasty (DSEK/DSAEK): 95% graft attachment, vision 20/40 in 6 months.

Statistic 73

Orbital decompression for thyroid eye disease: proptosis reduction 4-6mm in 85%.

Statistic 74

Pars plana vitrectomy volumes: 250,000 US yearly for various retinopathies.

Statistic 75

SMILE laser surgery for myopia: 98% safety index, ectasia risk <0.1%.

Statistic 76

Chalazion excisions: recurrence 10-20%, steroid injection alternative 80% resolution.

Statistic 77

Iris repair post-trauma: functional success 90% with pupilloplasty.

Statistic 78

Anti-VEGF intravitreal injections precede surgery in 40% wet AMD cases.

Statistic 79

Penetrating keratoplasty rejection rates 20% first year, topical steroids reduce to 10%.

Statistic 80

Total knee replacement surgeries in the US numbered 790,000 in 2021, with 90% patient satisfaction at 1 year.

Statistic 81

Hip fracture surgeries worldwide exceed 1.6 million annually, with 20-30% one-year mortality in elderly patients.

Statistic 82

Anterior cruciate ligament (ACL) reconstructions reached 400,000 globally in 2023, with graft failure rates under 5% using autografts.

Statistic 83

Spinal fusion surgeries in the US grew to 489,000 in 2022, costing $36 billion amid opioid crisis links.

Statistic 84

Rotator cuff repair procedures increased 20% from 2010-2020, with arthroscopic methods yielding 85% success.

Statistic 85

Osteoarthritis drives 70% of joint replacements; UK data shows 110,000 knee/hip surgeries yearly with 95% 10-year implant survival.

Statistic 86

Robotic-assisted knee arthroplasty adoption hit 25% in 2023, reducing alignment errors by 40% vs. manual.

Statistic 87

Ankle fracture fixations total 300,000 in Europe annually, with syndesmotic injuries in 20% requiring specialized hardware.

Statistic 88

Scoliosis correction surgeries in adolescents number 30,000 US yearly, with 90% curve correction and low neurologic risks.

Statistic 89

Periprosthetic joint infections occur in 1-2% of hip/knee replacements, necessitating 2-stage revisions in 70% cases.

Statistic 90

Total shoulder arthroplasty volumes rose 173% from 2001-2013, stabilizing at 70,000 US annually by 2022.

Statistic 91

Fracture nonunion rates post-tibial plating are 5-10%, improved to 2% with bone morphogenetic proteins.

Statistic 92

Hand surgery for carpal tunnel release exceeds 600,000 US yearly, with endoscopic technique halving recovery time.

Statistic 93

Revision hip arthroplasty rates are 13% at 10 years, rising to 36% by 20 years per national registries.

Statistic 94

Sports-related orthopedic surgeries cost US $10 billion annually, with meniscus repairs comprising 25%.

Statistic 95

Cementless hip implants show 98% survival at 10 years vs. 95% cemented in young patients.

Statistic 96

Pediatric supracondylar humerus fractures require surgery in 20%, with nerve injury risks at 10%.

Statistic 97

Augmented reality in orthopedic surgery improves screw placement accuracy to 98% in spine procedures.

Statistic 98

US foot and ankle surgeries total 1 million yearly, bunionectomies at 30% with 90% satisfaction.

1/98

Sources

Trusted by 500+ publications

+497

While traditional open heart surgeries may be declining, the field of surgery is being revolutionized by astonishing precision and success rates, such as the over 95% success for minimally invasive mitral valve repairs and a 28 million cataract procedures restoring sight worldwide.

Key Takeaways

In 2022, approximately 240,000 coronary artery bypass graft (CABG) surgeries were performed in the United States, marking a 5% decline from 2019 due to minimally invasive alternatives.
The global market for cardiac surgery devices reached $12.5 billion in 2023, driven by an 8% annual growth in valve replacement procedures.
Success rate of minimally invasive mitral valve repair surgery exceeds 95% in high-volume centers, with operative mortality under 1% as per 2021 data.
Total knee replacement surgeries in the US numbered 790,000 in 2021, with 90% patient satisfaction at 1 year.
Hip fracture surgeries worldwide exceed 1.6 million annually, with 20-30% one-year mortality in elderly patients.
Anterior cruciate ligament (ACL) reconstructions reached 400,000 globally in 2023, with graft failure rates under 5% using autografts.
Appendectomies in the US numbered 340,000 in 2021, with laparoscopic approach in 85% reducing stays to 1 day.
Cholecystectomies reached 1.2 million globally in 2022, bile duct injuries at 0.5% in lap vs. 0.2% open.
Hernia repairs total 800,000 US annually, mesh usage in 95% with recurrence <2% at 5 years.
Craniotomies for tumor resection in the US total 50,000 annually, with 90% gross total resection in gliomas.
Anterior cervical discectomy and fusion (ACDF) procedures reached 200,000 US in 2022, 95% success for radiculopathy.
Deep brain stimulation (DBS) for Parkinson's implanted in 15,000 patients yearly worldwide, improving motor scores by 50%.
Cataract surgeries worldwide exceeded 28 million in 2022, with intraocular lens implants restoring 20/40 vision in 95%.
LASIK procedures in the US totaled 800,000 in 2023, 96% achieving 20/20 uncorrected vision.
Retinal detachment repairs number 50,000 US annually, anatomical success 90% with vitrectomy.

Cardiac surgeries are declining as safer, minimally invasive procedures rapidly gain popularity.

Abdominal and General Surgery

Appendectomies in the US numbered 340,000 in 2021, with laparoscopic approach in 85% reducing stays to 1 day.
Cholecystectomies reached 1.2 million globally in 2022, bile duct injuries at 0.5% in lap vs. 0.2% open.
Hernia repairs total 800,000 US annually, mesh usage in 95% with recurrence <2% at 5 years.
Colorectal resections for cancer hit 150,000 US in 2023, laparoscopic in 60% with 80% 5-year survival.
Bariatric surgeries grew to 260,000 US in 2022, sleeve gastrectomy 60% with 50-70% excess weight loss.
Colectomy volumes declined 10% post-COVID due to screening pauses, per 2023 NIS data.
Pancreatoduodenectomies (Whipple) mortality fell to 2-5% in high-volume centers (>20/year).
Inguinal hernia recurrence post-laparoscopic TEP is 3.6% vs. 1.7% open Lichtenstein at 5 years.
Esophagectomies number 8,000 US yearly, minimally invasive reducing pulmonary complications by 40%.
Ventral hernia repairs with biologic mesh show 15% recurrence vs. 25% synthetic in contaminated fields.
Adrenalectomies for pheochromocytoma total 2,000 US, laparoscopic in 90% with <1% mortality.
Splenectomies declined 60% since 2000 due to angioembolization, now 40,000 US yearly.
Gastrectomies for gastric cancer: 5-year survival post-R0 resection 70% in early stages.
Liver resections for HCC reached 50,000 globally, robotic approach halving blood loss.
Small bowel obstructions require surgery in 20%, adhesiolysis with 10% recurrence risk.
Thyroidectomies total 70,000 US for cancer, hypocalcemia in 30% transient post-op.
Parathyroidectomies cure hyperparathyroidism in 95%, minimally invasive in 80%.
Perforated ulcer surgeries: 90% survival with early lap repair, sepsis mortality 20%.

Abdominal and General Surgery Interpretation

While surgeons are meticulously mastering minimally invasive techniques to shorten recoveries and improve outcomes—from banishing appendixes in a day to boosting cancer survival rates—these statistics soberly remind us that the scalpel's touch, whether through a tiny incision or open, remains a profound balance of art, risk, and lifesaving precision.

Cardiovascular Surgery

In 2022, approximately 240,000 coronary artery bypass graft (CABG) surgeries were performed in the United States, marking a 5% decline from 2019 due to minimally invasive alternatives.
The global market for cardiac surgery devices reached $12.5 billion in 2023, driven by an 8% annual growth in valve replacement procedures.
Success rate of minimally invasive mitral valve repair surgery exceeds 95% in high-volume centers, with operative mortality under 1% as per 2021 data.
In Europe, transcatheter aortic valve replacement (TAVR) procedures increased by 25% from 2020 to 2023, totaling over 100,000 annually.
Postoperative atrial fibrillation occurs in 30-40% of CABG patients, contributing to 20% longer hospital stays according to a 2022 meta-analysis.
Robotic-assisted cardiac surgery adoption rose to 15% of all heart valve procedures in the US by 2023, reducing blood transfusion needs by 25%.
Lifetime risk of requiring heart valve surgery is 1 in 75 for men and 1 in 100 for women over age 50, per UK Biobank study.
In 2021, India performed over 50,000 open-heart surgeries, with a 98% survival rate in pediatric cases at top centers.
Hybrid coronary revascularization procedures grew 12% yearly, combining PCI and CABG, with 90% patency rates at 5 years.
Sternal wound infections complicate 1-5% of median sternotomy cardiac surgeries, linked to 20% increased mortality.
In 2023, China reported 300,000 cardiac surgeries, with off-pump CABG comprising 60% to minimize complications.
5-year survival post-CABG for left main disease is 85-90%, superior to medical therapy alone per 2022 trials.
Pediatric congenital heart surgery volumes in the US hit 12,000 annually, with 97% survival for simple repairs.
Intra-aortic balloon pump usage in high-risk cardiac surgery dropped to 10% due to Impella devices, improving hemodynamics.
Women undergoing cardiac surgery have 1.5 times higher mortality risk than men, adjusted for comorbidities per 2023 registry.
Global cardiac surgery wait times average 3-6 months in public systems, leading to 10% preventable deaths.
3D printing for patient-specific cardiac models reduced operative time by 22% in complex valve surgeries.
In 2022, Australia performed 25,000 cardiac procedures, with Indigenous patients showing 2x complication rates.
Endocarditis-related valve surgeries increased 15% post-COVID, with 40% involving multidrug-resistant organisms.
AI predictive models for cardiac surgery risk achieve 92% accuracy in mortality prediction over traditional scores.

Cardiovascular Surgery Interpretation

While the scalpel is being gently nudged aside by catheters and robots, the heart of cardiac surgery remains a triumph of modern science—a field where mortality plummets as innovation soars, yet sobering disparities in access and outcome remind us that the pulse of progress must beat for all.

Neurosurgery

Craniotomies for tumor resection in the US total 50,000 annually, with 90% gross total resection in gliomas.
Anterior cervical discectomy and fusion (ACDF) procedures reached 200,000 US in 2022, 95% success for radiculopathy.
Deep brain stimulation (DBS) for Parkinson's implanted in 15,000 patients yearly worldwide, improving motor scores by 50%.
Aneurysm clipping vs. coiling: surgical clipping used in 30% complex cases with 92% occlusion rates.
Spinal cord tumor resections: intramedullary gross total removal in 70%, neurologic preservation 85%.
Endoscopic third ventriculostomy success for hydrocephalus is 70% in adults, avoiding shunt dependency.
Awake craniotomy for eloquent gliomas allows 80% resection increase, preserving language function in 95%.
Chiari malformation decompression surgeries total 5,000 US yearly, symptom relief in 80-90%.
Pituitary adenoma transsphenoidal resections: 85% biochemical remission for acromegaly.
Trigeminal neuralgia microvascular decompression yields 80% pain-free at 10 years.
Stereotactic radiosurgery (SRS) for brain mets: local control 85% at 1 year, used in 50,000 cases globally.
Lumbar microdiscectomies number 500,000 worldwide annually, 90% leg pain relief.
Carotid endarterectomy reduces stroke risk by 65% in symptomatic stenosis >70%.
Pediatric neurosurgery for spina bifida closure: 90% survival, hydrocephalus shunt in 80%.
Laser interstitial thermal therapy (LITT) for epilepsy: seizure freedom in 60% focal cases.
Moyamoya revascularization: stroke reduction 80% post-direct bypass in adults.
Intracranial pressure monitoring in TBI: used in 20% severe cases, mortality drop 15%.
Radiosurgery for trigeminal schwannoma: 95% tumor control, facial preservation 98%.
Minimally invasive spine surgery (MISS) adoption 40%, blood loss 50% less than open.
Arteriovenous malformation (AVM) microsurgery obliteration 95% Spetzler-Martin grade I/II.
Ventriculoperitoneal shunt infections occur in 5-10%, revisions in 40% first year.

Neurosurgery Interpretation

Neurosurgeons are walking a high-wire act, routinely hitting 90% home runs with brain tumors while managing a staggering volume of spine repairs and performing thousands of delicate brain procedures that, despite a constant risk of complications and revisions, profoundly relieve suffering and redefine survival.

Ophthalmic Surgery

Cataract surgeries worldwide exceeded 28 million in 2022, with intraocular lens implants restoring 20/40 vision in 95%.
LASIK procedures in the US totaled 800,000 in 2023, 96% achieving 20/20 uncorrected vision.
Retinal detachment repairs number 50,000 US annually, anatomical success 90% with vitrectomy.
Glaucoma trabeculectomy surgeries: 70-80% intraocular pressure control at 5 years.
Corneal transplants (PK) global volume 200,000 yearly, graft survival 90% at 1 year.
Strabismus surgeries in children: 120,000 US, alignment success 75% single procedure.
Diabetic vitrectomy for vitreous hemorrhage: visual acuity improvement in 80%.
Pterygium excisions with conjunctival autograft: recurrence <5% vs. 30% bare sclera.
Dacryocystorhinostomy (DCR) success 95% for nasolacrimal duct obstruction.
Macular hole repairs with ILM peeling: anatomical closure 95%, vision gain 70%.
Phacoemulsification cataract complications: posterior capsule rupture 1-2%.
Refractive lens exchange for presbyopia: 90% spectacle independence post-multifocal IOL.
Endothelial keratoplasty (DSEK/DSAEK): 95% graft attachment, vision 20/40 in 6 months.
Orbital decompression for thyroid eye disease: proptosis reduction 4-6mm in 85%.
Pars plana vitrectomy volumes: 250,000 US yearly for various retinopathies.
SMILE laser surgery for myopia: 98% safety index, ectasia risk <0.1%.
Chalazion excisions: recurrence 10-20%, steroid injection alternative 80% resolution.
Iris repair post-trauma: functional success 90% with pupilloplasty.
Anti-VEGF intravitreal injections precede surgery in 40% wet AMD cases.
Penetrating keratoplasty rejection rates 20% first year, topical steroids reduce to 10%.

Ophthalmic Surgery Interpretation

From restoring sight with stunning precision to battling stubborn eyelid bumps, modern ophthalmology offers an arsenal of procedures with remarkably high success rates, giving us a clear-eyed view of its triumphs and ongoing challenges.

Orthopedic Surgery

Total knee replacement surgeries in the US numbered 790,000 in 2021, with 90% patient satisfaction at 1 year.
Hip fracture surgeries worldwide exceed 1.6 million annually, with 20-30% one-year mortality in elderly patients.
Anterior cruciate ligament (ACL) reconstructions reached 400,000 globally in 2023, with graft failure rates under 5% using autografts.
Spinal fusion surgeries in the US grew to 489,000 in 2022, costing $36 billion amid opioid crisis links.
Rotator cuff repair procedures increased 20% from 2010-2020, with arthroscopic methods yielding 85% success.
Osteoarthritis drives 70% of joint replacements; UK data shows 110,000 knee/hip surgeries yearly with 95% 10-year implant survival.
Robotic-assisted knee arthroplasty adoption hit 25% in 2023, reducing alignment errors by 40% vs. manual.
Ankle fracture fixations total 300,000 in Europe annually, with syndesmotic injuries in 20% requiring specialized hardware.
Scoliosis correction surgeries in adolescents number 30,000 US yearly, with 90% curve correction and low neurologic risks.
Periprosthetic joint infections occur in 1-2% of hip/knee replacements, necessitating 2-stage revisions in 70% cases.
Total shoulder arthroplasty volumes rose 173% from 2001-2013, stabilizing at 70,000 US annually by 2022.
Fracture nonunion rates post-tibial plating are 5-10%, improved to 2% with bone morphogenetic proteins.
Hand surgery for carpal tunnel release exceeds 600,000 US yearly, with endoscopic technique halving recovery time.
Revision hip arthroplasty rates are 13% at 10 years, rising to 36% by 20 years per national registries.
Sports-related orthopedic surgeries cost US $10 billion annually, with meniscus repairs comprising 25%.
Cementless hip implants show 98% survival at 10 years vs. 95% cemented in young patients.
Pediatric supracondylar humerus fractures require surgery in 20%, with nerve injury risks at 10%.
Augmented reality in orthopedic surgery improves screw placement accuracy to 98% in spine procedures.
US foot and ankle surgeries total 1 million yearly, bunionectomies at 30% with 90% satisfaction.

Orthopedic Surgery Interpretation

While orthopedic surgery has achieved remarkably high success rates for elective procedures like knee replacements, it still faces grim mortality statistics in trauma cases such as hip fractures, revealing a field defined by both its technological triumphs and its sobering, high-stakes realities.

Sources & References

Logos provided by Logo.dev